DCF — METHODIST RICHARDSON MEDICAL CENTER
Enterprise Value: $598.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$598.2M
Enterprise Value
$165.0M
PV of Cash Flows
$433.2M
PV of Terminal Value
$697.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $462.6M | $70.0M | 15.0% | $35.8M | $32.6M |
| Year 2 | $476.5M | $76.9M | 16.0% | $40.5M | $33.4M |
| Year 3 | $490.8M | $84.1M | 17.0% | $45.4M | $34.1M |
| Year 4 | $505.5M | $89.1M | 18.0% | $48.6M | $33.2M |
| Year 5 | $520.7M | $93.1M | 18.0% | $51.0M | $31.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $598.2M. Terminal value accounts for 72% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$449.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.14632785015878647
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5